Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Summary

The primary objective of this study is to assess the pharmacokinetics (PK) of linzagolix in subjects with varying degrees of impaired renal function compared to matched control subjects with normal renal function

Timeline

Start

2019-05-15

Primary completion

2020-01-22

Completion

2020-01-31

Drugs

Indications